Modeling, state estimation, and optimal control for the US COVID-19 outbreak.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 18 04 2020
accepted: 03 06 2020
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 16 7 2020
Statut: epublish

Résumé

The novel coronavirus SARS-CoV-2 and resulting COVID-19 disease have had an unprecedented spread and continue to cause an increasing number of fatalities worldwide. While vaccines are still under development, social distancing, extensive testing, and quarantining of confirmed infected subjects remain the most effective measures to contain the pandemic. These measures carry a significant socioeconomic cost. In this work, we introduce a novel optimization-based decision-making framework for managing the COVID-19 outbreak in the US. This includes modeling the dynamics of affected populations, estimating the model parameters and hidden states from data, and an optimal control strategy for sequencing social distancing and testing events such that the number of infections is minimized. The analysis of our extensive computational efforts reveals that social distancing and quarantining are most effective when implemented early, with quarantining of confirmed infected subjects having a much higher impact. Further, we find that "on-off" policies alternating between strict social distancing and relaxing such restrictions can be effective at "flattening" the curve while likely minimizing social and economic cost.

Identifiants

pubmed: 32612204
doi: 10.1038/s41598-020-67459-8
pii: 10.1038/s41598-020-67459-8
pmc: PMC7329889
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

10711

Subventions

Organisme : National Science Foundation
ID : CAREER Award 1454433
Pays : International

Références

Peeri, N. C. et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?. Int. J. Epidemiol. https://doi.org/10.1093/ije/dyaa033 (2020).
doi: 10.1093/ije/dyaa033 pubmed: 32086938 pmcid: 7197734
Sohrabi, C. et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int. J. Surg. 76, 71–76 (2020).
doi: 10.1016/j.ijsu.2020.02.034
Paterlini, M. Lockdown in Italy: personal stories of doing science during the COVID-19 quarantine. Nature: Career Feature https://doi.org/10.1038/d41586-020-01001-8 (2020).
doi: 10.1038/d41586-020-01001-8
Tobías, A. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up. Sci. Total Environ. https://doi.org/10.1016/j.scitotenv.2020.138539 (2020).
doi: 10.1016/j.scitotenv.2020.138539 pubmed: 32330703 pmcid: 7166106
Kraemer, M. U. et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science https://doi.org/10.1126/SCIENCE.ABB4218 (2020).
doi: 10.1126/SCIENCE.ABB4218 pubmed: 32234804 pmcid: 7164389
Gostic, K., Gomez, A. C., Mummah, R. O., Kucharski, A. J. & Lloyd-Smith, J. O. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. eLife 9, e55570 (2020).
doi: 10.7554/eLife.55570
Keeling, M. J. & Rohani, P. Modeling Infectious Diseases in Humans and Animals (Princeton University Press, Princeton, 2011).
doi: 10.2307/j.ctvcm4gk0
Anastassopoulou, C., Russo, L., Tsakris, A. & Siettos, C. Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS One 15, e0230405 (2020).
doi: 10.1371/journal.pone.0230405
Peng, L., Yang, W., Zhang, D., Zhuge, C. & Hong, L. Epidemic analysis of COVID-19 in China by dynamical modeling. arXiv preprint arXiv:2002.06563 (2020).
Magal, P., & Webb, G. Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea. medRxiv 2020.03.21.20040154 (2020).
Kucharski, A. J. et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect. Dis. 20, 553–558 (2020).
doi: 10.1016/S1473-3099(20)30144-4
Liu, Y., Gayle, A. A., Wilder-Smith, A. & Rocklöv, J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 27, taaa021 (2020).
doi: 10.1093/jtm/taaa021
Liu, Z., Magal, P., Seydi, O. & Webb, G. Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data. arXiv preprint arXiv:2002.12298 (2020).
Park, S. W., Cornforth, D. M., Dushoff, J. & Weitz, J. S. The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak. medRxiv 2020.03.09.20033514 (2020).
Wu, J. T., Leung, K. & Leung, G. M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 395, 689–697 (2020).
doi: 10.1016/S0140-6736(20)30260-9
Sameni, R. Mathematical modeling of epidemic diseases; a case study of the COVID-19 coronavirus. arXiv preprint arXiv:2003.11371 (2020).
Pan, J. et al. Effectiveness of control strategies for coronavirus disease 2019: a SEIR dynamic modeling study. medRxiv 2020.02.19.20025387 (2020).
Djidjou-Demasse, R., Michalakis, Y., Choisy, M., Sofonea, M. T. & Alizon, S. Optimal COVID-19 epidemic control until vaccine deployment. medRxiv 2020.04.02.2004918 (2020).
Moore, S. E. & Okyere, E. Controlling the transmission dynamics of COVID-19. arXiv preprint arXiv:2004.00443 (2020).
Lenhart, S. & Workman, J. T. Optimal Control Applied to Biological Models (CRC Press, Boca Raton, 2007).
doi: 10.1201/9781420011418
Biswas, M. H. A., Paiva, L. T. & De Pinho, M. A SEIR model for control of infectious diseases with constraints. Math. Biosci. Eng. 11, 761–784 (2014).
doi: 10.3934/mbe.2014.11.761
Neilan, R. M. & Lenhart, S. An introduction to optimal control with an application in disease modeling. Model. Parad. Anal. Dis. Transm. Models 67–82 (2010).
Biegler, L. T. An overview of simultaneous strategies for dynamic optimization. Chem. Eng. Process. Process Intensif. 46, 1043–1053 (2007).
doi: 10.1016/j.cep.2006.06.021
Floudas, C. A. Deterministic Global Optimization: Theory, Methods and Applications Vol. 37 (Springer Science and Business Media, New York, 2013).
Mizumoto, K., Kagaya, K., Zarebski, A. & Chowell, G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance 25, 2000180 (2020).
doi: 10.2807/1560-7917.ES.2020.25.10.2000180
Nishiura, H. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int. J. Infect. Dis. 94, 154–155 (2020).
doi: 10.1016/j.ijid.2020.03.020
Bai, Y. et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 323, 1406–1407 (2020).
doi: 10.1001/jama.2020.2565
Rocklöv, J., Sjödin, H. & Wilder-Smith, A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J. Travel Med. 27, taaa030 (2020).
doi: 10.1093/jtm/taaa030
Bendavid, E. et al. COVID-19 Antibody Seroprevalence in Santa Clara County, California. medRxiv 2020.04.14.20062463 (2020).
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J. & Hsueh, P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents 55, 105924 (2020).
doi: 10.1016/j.ijantimicag.2020.105924
Ferguson, N. M. et al.Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand (Tech. Rep, Imperial College London, 2020).
Anderson, R. M., Heesterbeek, H., Klinkenberg, D. & Hollingsworth, T. D. How will country-based mitigation measures influence the course of the COVID-19 epidemic?. Lancet 395, 931–934 (2020).
doi: 10.1016/S0140-6736(20)30567-5
Wan, E. A. & Van Der Merwe, R. The unscented Kalman filter for nonlinear estimation. In Proceedings of the IEEE 2000 Adaptive Systems for Signal Processing, Communications, and Control Symposium (Cat. No. 00EX373), 153–158 (IEEE, 2000).
Hart, W. E. et al.Pyomo-optimization Modeling in Python Vol. 67 (Springer, New York, 2017).
doi: 10.1007/978-3-319-58821-6
Wächter, A. & Biegler, L. T. On the implementation of an interior-point filter line-search algorithm for large-scale nonlinear programming. Math. Program. 106, 25–57 (2006).
doi: 10.1007/s10107-004-0559-y
Process Systems Enterprise. general PROcess Modeling System (gPROMS) http://www.psenterprise.com/products/gproms (1997–2020).
Tawarmalani, M. & Sahinidis, N. V. A polyhedral branch-and-cut approach to global optimization. Math. Program. 103, 225–249 (2005).
doi: 10.1007/s10107-005-0581-8

Auteurs

Calvin Tsay (C)

McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.

Fernando Lejarza (F)

McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.

Mark A Stadtherr (MA)

McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.

Michael Baldea (M)

McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA. mbaldea@che.utexas.edu.
Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin, TX, USA. mbaldea@che.utexas.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH